Bioburden Testing

World Market Report

MCP10706

EXECUTIVE ENGAGEMENTS

POOL

3577
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

644
Interactions with Platform & by Email

PARTICIPANTS

107
Unique # Participated

VALIDATIONS

31
Responses Validated*

COMPANIES

41
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

102

PAGES

173

EDITION

5

PRICE

USD 5450

CODE

MCP10706


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Bioburden Testing Market to Reach $1.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Bioburden Testing estimated at US$698.6 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 11.2% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 11.8% CAGR and reach US$946.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instrument segment is readjusted to a revised 10.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $206.1 Million, While China is Forecast to Grow at 10.8% CAGR
The Bioburden Testing market in the U.S. is estimated at US$206.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$257.7 Million by the year 2027 trailing a CAGR of 10.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.9% and 9.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

SELECT PLAYERS

ATS Laboratories, Inc.; Becton, Dickinson and Company; Charles River Laboratories International, Inc.; Merck & Co., Inc.; North American Science Associates, Inc.; Pacific Biolabs; SGS Group (SGS SA); Sigma-Aldrich Corporation

SEGMENTS

» Product (Consumables, Instrument) » Test Type (Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing, Spore Count Testing) » End-Use (Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Bioburden Testing – Global Key Competitors Percentage Market Share in 2020 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Bioburden Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Bioburden Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Bioburden Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Instrument by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Instrument by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Instrument by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Bioburden Testing Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Aerobic Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Aerobic Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Aerobic Count Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Anaerobic Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Anaerobic Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Anaerobic Count Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Fungi / Mold Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Fungi / Mold Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Fungi / Mold Count Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Spore Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Spore Count Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Spore Count Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
UNITED STATES
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2020 (E)
USA Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
USA Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
USA Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
USA Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
USA Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
USA Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Canada Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Canada Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
JAPAN
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2020 (E)
Japan Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Japan Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Japan Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
CHINA
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2020 (E)
China Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
China Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
China Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
China Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
China Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
China Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
EUROPE
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2020 (E)
Europe Recent Past, Current & Future Analysis for Bioburden Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Europe Historic Review for Bioburden Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Bioburden Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2019 & 2027
Europe Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Europe Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Europe Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
FRANCE
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2020 (E)
France Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
France Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
France Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
France Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
France Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
France Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
GERMANY
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2020 (E)
Germany Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Germany Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Germany Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Italy Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Italy Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
UNITED KINGDOM
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2020 (E)
UK Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
UK Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
UK Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
UK Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
UK Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
UK Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
ASIA-PACIFIC
Bioburden Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2020 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Bioburden Testing by Product - Consumables and Instrument - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Bioburden Testing by Product - Consumables and Instrument Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Bioburden Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instrument for the Years 2012, 2019 & 2027
Rest of World Recent Past, Current & Future Analysis for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Bioburden Testing by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Bioburden Testing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Contract Manufacturing Organizations and Other End-Uses for the Years 2012, 2019 & 2027
Rest of World Recent Past, Current & Future Analysis for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Bioburden Testing by Test Type - Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Bioburden Testing by Test Type - Percentage Breakdown of Value Sales for Aerobic Count Testing, Anaerobic Count Testing, Fungi / Mold Count Testing and Spore Count Testing for the Years 2012, 2019 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com